Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 1,476,035 |
|
|||||
| News | - | ||||||
| Day High | 0.15 | Low High |
|||||
| Day Low | 0.1366 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.008 | 5.76% | 0.147 | 16:30:14 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.14 | 0.1366 | 0.15 | 0.147 | 0.139 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 137 | 1,476,035 | $ 0.14641 | $ 216,106 | - | 0.1275 - 0.418 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:58:00 | 5,000 | $ 0.147 | USD |
CytoDyn Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 146.93M | 921.12M | 556.02M | 0 | -79.82M | -0.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
CytoDyn (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.148 | 0.15 | 0.1285 | 0.1394954 | 1,189,906 | -0.001 | -0.68% |
| 1 Month | 0.167 | 0.17 | 0.1275 | 0.1493299 | 1,167,924 | -0.02 | -11.98% |
| 3 Months | 0.1649 | 0.28 | 0.1275 | 0.1828856 | 2,221,494 | -0.0179 | -10.86% |
| 6 Months | 0.155 | 0.418 | 0.1275 | 0.194713 | 2,663,869 | -0.008 | -5.16% |
| 1 Year | 0.2701 | 0.418 | 0.1275 | 0.204022 | 1,987,850 | -0.1231 | -45.58% |
| 3 Years | 3.14 | 3.20 | 0.1275 | 0.6787454 | 2,189,010 | -2.99 | -95.32% |
| 5 Years | 0.405 | 10.01 | 0.1275 | 2.17 | 2,876,786 | -0.258 | -63.70% |
CytoDyn (QB) Description
| CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. |
